Summary of Study ST001369

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000922. The data can be accessed directly via it's Project DOI: 10.21228/M8HH5M This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Show all samples  |  Perform analysis on untargeted data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST001369
Study TitleGrass pollen sublingual immunotherapy treatment induces transcriptomic and metabolic changes due to AIT treatment
Study Summary47 patients were enrolled in a double-blind, placebo-controlled, multicenter trial using with GRAZAX® (Phleum pretense) during 2 years of therapy (T2). Immunological assays such as sIgE, sIgG4 and ISAC were carried out to the 31 patients who finished the trial. Additionally, serum and PBMCs samples from these samples were analyzed by metabolomics and transcriptomics, respectively. Based on their sensitization level, 22 patients were grouped in Mono and Poli groups, excluding epithelial allergic patients. Individuals were studied based on their treatment in Active and Placebo and their sensitization level. For metabolomics, samples were analyzed by Liquid and Gas Chromatography coupled to Mass Spectrometry (LC-MS and GC-MS, respectively).
Institute
Institute of Applied Molecular Medicine;The Centre of Metabolomics and Bioanalysis
Last NameObeso Montero
First NameDavid
AddressAvda. Monteprincipe s/n 28668 Boadilla del Monte, Madrid, España
Emaildavid.obesomontero@beca.ceu.es
PhoneTlf: 91 372 47 00 ext. 4662
Submit Date2020-03-27
Num Groups2 main groups: Active and Placebo, and 2 subgroups: Monosensitized and Polisensitized patients.
Total Subjects22
Study Commentshttps://www.ceu.es;http://www.metabolomica.uspceu.es
Raw Data AvailableYes
Raw Data File Type(s)d
Analysis Type DetailGC-MS/LC-MS
Release Date2020-09-29
Release Version1
David Obeso Montero David Obeso Montero
https://dx.doi.org/10.21228/M8HH5M
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Combined analysis:

Analysis ID AN002283 AN002284 AN002285
Analysis type MS MS MS
Chromatography type Reversed phase Reversed phase GC
Chromatography system Agilent 1200 Agilent 1200 Agilent 7890A
Column Discovery HS C18 (150 x 2.1mm,3.0um) Supelco,Sigma Aldrich,Germany),with a guard Discovery HS C18 (2 cm x 2.1mm,3um; Supelco,Sigma Aldrich,Germany), Discovery HS C18 (150 x 2.1mm,3.0um) Supelco,Sigma Aldrich,Germany) GC-Column DB5-MS (30 m length, 0.25 mm i.d., 0.25 μm film 95% dimethyl/5% diphenylpolysiloxane) with an integrated precolumn (10 m J&W, Agilent)
MS Type ESI ESI EI
MS instrument type QTOF QTOF Single quadrupole
MS instrument name Agilent 6520 QTOF Agilent 6520 QTOF Agilent 5975C
Ion Mode POSITIVE NEGATIVE POSITIVE
Units peak area peak area peak area
  logo